Associated Papers
Reannotation of cancer mutations based on expressed RNA transcripts reveals functional non-coding mutations in melanoma.
Pepe D et al.
American Journal of Human Genetics, 2025
40359938 (PubMed )
Supplement: mmc6.xlsx › Sheet_1
Loss-of-function mutations of SOX17 lead to YAP/TEAD activation-dependent malignant transformation in endometrial cancer.
Wang M et al.
Oncogene, 2023
Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy.
Neron M et al.
Journal of Personalized Medicine, 2022
35629078 (PubMed )
Supplement: jpm-12-00655-s001.zip › Supplementary_tables__MC20220419.xlsx › Table_S4
Cancer-associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17.
Srivastava Y et al.
The Febs Journal, 2020
Novel SOX17 frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutations.
Walker CJ et al.
Oncotarget, 2017
Select a paper to view details